LEI 959800T0XY1149VHYP17
ONCOMATRYX BIOPHARMA SA
Contract awards & public grants
Pioneering antibody-drug conjugates targeting the tumour microenvironment to deliver transformative new therapies in oncology → ONCOMATRYX BIOPHARMA SA
European Commission · ES · Grant · 2025-10-31
€2.5M
Boosting future REsearchers in biomaterials for Advanced healTH solutions → ONCOMATRYX BIOPHARMA SA
European Commission · ES · Grant · 2025-05-06
—
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.